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induced a phenotype that was called "wrinkled skin." The 
"wrinkled skin" phenotype was characterized by an out-pouch­
ing involving the entire graft site, with irregularly distributed 
furrows and fine wrinkles, and punctate hyperpigmentation 
frequently limited to 1-2 mm hyperkeratotic surface protrusions. 
The "wrinkled skin" phenotype persists at least for 12 weeks. In 
addition, LF24 cells enhanced hair growth in grafts of HF buds 
as compared to Swiss 3T3, or when combined with fresh dermal 
cells from newborn mice (containing dermal papilla cells). 
Histochemical analysis of the "wrinkled skin" revealed the 
presence of large cornified surface protrusions that were fre­
quently associated with enlarged sebaceous glands and melano­
cytes. A mild "wrinkled skin" phenotype could be obtained with 
the parent A31 cells as well, but not with Swiss 3T3 fibroblasts, 
used as a control cell line, or with keratinocyte growth factor 
(KGF)-overexpressing Swiss 3T3 cells, or with hepatocyte 
growth factor (HGF)-overexpressing NIH 3T3 cells (Lichti et aI, 
this issue). Thus, the "wrinkled skin" phenotype depended on 
the fibroblast cells used in grafts and might be due to the specific 
diffusible factor(s) secreted by LF24 cells. 
Proliferation of the epidermal and dermal cells in graft areas of 
the "wrinkled skin" was studied by injecting BrdU into grafted 
animals 2 h prior to sacrifice at 3, 4, 6, 8, and 10 weeks. Immuno­
histochemical analysis using BrdU-specific antibodies was performed 
on paraffin-embedded sections of ci1e skin samples from the LF24, 
A31, and Swiss 3T3 (control) grafts. BrdU labeling showed a high 
level of proliferation at 3- 4 weeks after grafting in epidermis and 
adjacent dermis in LF24 grafts. At 8 -1 0 weeks the proliferation was 
confined to the area of epidermal protrusions. These experiments 
demonstrated that the "wrinkled skin" phenotype was established 
between the third and the fourth week after grafting and persisted 
through week ten, when increased proliferation was detected focally. 
To demonstrate the presence of a specific factor(s) in the 
conditioned medium obtained from LF24 cells, confluent cultures of 
primary mouse keratinocytes in 0.05 mM Ca ++ medium were treated 
with different media, and cell proliferation was scored by counting 
detached cells every other day for a period of 2 weeks. LF24-
conditioned medium stimulated keratinocyte proliferation to a much 
higher extent, as compared to eici1er control medium or medium 
conditioned by Swiss 3T3 fibroblasts. From these experiments, it was 
concluded iliat the LF24 cells secreted specific growth factor(s) iliat 
could stimulate proliferation of confluent primary keratinocytes. 
Experiments were performed to test for the presence of 
growth factor(s) in LF24-conditioned medium that might work 
through either an EGF receptor or a mitogen-activated protein 
(MAP) kinase pathway. Several well-known growth factors, 
such as epidermal growth factor (EGF) , transforming growth 
factor-alpha (TGFa), acidic and basic fibroblast growth factors 
(FGFs), keratinocyte growth factor, HGF, and insulin-like 
growth factor (IGF-l) are very potent mitogens for epithelial 
cells. One of these factors or a combination of them might be 
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responsible for the "wrinkled skin." Concentration ofTGFa, an 
EGF-receptor ligand, in both LF24- and Swiss 3T3-conditioned 
media, was measured by radioimmunoassay (in collaboration 
with Dr. Robert J. Coffey, Vanderbilt University, Nashville, 
TN) and was similar to non-conditioned medium. Using West­
ern blot analysis and antibodies specific for 1) EGF receptor, 2) 
phosphotyrosine, and 3) MAP kinase, the phosphorylation levels 
of both EGF receptor and MAP kinase in primary mouse 
keratinocytes as well as in a human epithelial cell line, A 431 
(overexpressing EGF receptor), were compared after a short 
exposure to control medium, supplemented with EGF (1-10 
ng/ml) or to LF24-conditioned medium. Although a clear 
phosphorylation of EGF receptor and MAP kinase was detected 
after treatment with 1 ng/ml EGF in control medium, no change 
in phosphorylation of either substrate was found after exposure 
to LF24-conditioned medium. In primary mouse keratinocytes, 
EGF, acidic FGF, KGF, and HGF when added to standard 
growth medium caused rapid phosphorylation of EGF receptor 
(EGF) and/or MAP kinase (EGF, acidic FGF, KGF, HGF), 
whereas basic FGF and IGF-1 had no effect.t From these data, it 
was concluded that either the concentration of the factor(s) 
working through EGF receptor/MAP kinase pathway in the 
LF24-conditioned medium was below the detection level, or 
that these factor(s) might work through an EGF receptor/MAP 
kinase independent pathway. In addition, TGFa, KGF, or HGF 
are unlikely to be solely responsible for the induction of 
"wrinkled skin" phenotype. 
To analyze further the differences between LF24 and Swiss 3T3 
secretions, 24-h serum-free conditioned media from both cell lines 
were collected, concentrated using centricon-3 filters, and the 
proteins were separated on 1D and 2D gels and visualized by silver 
staining. Several prominent spots were identified that were unique 
to LF24 medium. These proteins are undergoing microsequencing 
as potential candidates for the factor(s) responsible for the "wrin­
kled skin" phenotype. 
This work was supported ill part by grants frOIn tile NatiO//a1 Alopecia Areata 
Foundation to ABS and TK. 
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A
lopecia areata (AA) is microscopically character­
ized by peribulbar infiltration by T cells, predom­
inantly T -helper cells, and antigen-presenting 
cells, suggesting a cell-mediated immune mecha­
nism involved in the pathogenesis of the disease. 
Elucidation of the mechanism through which lesional alopecia 
areata T cells achieve and maintain their activated state is critical 
for the better understanding of the pathogenesis of the disease. 
T lymphocytes can be activated through multiple distinct 
but functionally related pathways. Such pathways can be dependent 
on antigens. Antigen-dependent T-cell activation occurs through 
interaction of the T-cell receptor (TCR) complex with nominal 
antigenic peptide bound to major histocompatibility complex pro­
teins expressed on the surface of antigen-presenting cells. The 
TCR-CDRJ region plays a critical role in the recognition of a 
particular antigen bound to a defined major histocompatibility 
complex (MHC) molecule. Isolation of specific TCR sequence 
rearrangements exclusively found in patients could lead to the 
identification of the relevant antigen in AA. 
The fraction of disease-relevant T cells is probably very small. 
New molecular biology techniques now open the possibility of 
defining a small subset of T cells with pathogenic relevance, 
responsible for the initiation and the perpetuation of the inflamma­
tory process that lead to hair loss. The ability to target only those T 
cells with a pathogenic role will consequently promote the design 
of novel immunotherapies to treat this disorder. 
To analyze the specificity of the immune response in AA patients, 
we analyzed the TCR repertoire V{3 chain expression in scalp 
affected areas. Four patients from the Dermatology clinic at the 
University of California San Francisco and four healthy controls 
were included in this preliminary study. Three of the patients have 
patchy AA of greater than 18 months duration and more than 25% 
of their scalp is affected. The remaining patient had been diagnosed 
with alopecia universalis for a period longer than 2 years. Scalp 
biopsies were taken from 1) the margin of an active patch during an 
active hair loss episode in two patients, 2) a regrowing area in the 
AU patient, and 3) normal hairy occipital region in controls. 
TCR V{3 repertoire expression was analyzed in scalp biopsies and 
blood samples, obtained from each person. After RNA extraction 
and synthesis of the first complementary DNA strand, TCR V{3 
sequences were amplified using specific primers for 24 V{3 families 
(Clontech Laboratories Inc., Palo Alto, CA) by the polymerase 
chain reaction (PCR) method [1]. PCR products were separated by 
electrophoresis, transferred to a nylon membrane, and hybridized 
with a biotinilated probe for the constant region of the TCR, 
according to Southern [2]. Relative frequencies of the different TCR 
V{3 families in scalp biopsies were compared to their frequencies in the 
peripheral blood lymphocytes (PBL), and patients versus controls. The 
results represent relative expression of each specific V{3 family in a 
given sample. In the majority of the samples, most of the TCR 
repertoire was expressed, except for one control sample that showed a 
very restricted pattern in skin. Overexpression varied from individual 
'to individual, but certain TCR V{3 families were more frequently 
found to be relatively overexpressed in skin or PBLs. 
We found that V{34, V{311, V{316, V{323, and V{324 families are 
preferentially expressed in PBLs (in eight of eight samples), In a 
previous report, Dunn and colleagues [3] suggested that V{35.1 was 
more frequently expressed in PBLs rather than in normal skin, In 
our study group, we found that V {35, 1 was overexpressed only in 
one AA patient and two controls. V{316 was clearly overexpressed 
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Figure 1. Relative TCR V/3 expression in patchy AA and con­
trol. TCR V{3 expression in PBL and skin from an active patchy AA 
patient and a controL This figure exemplifies the variation in the TCR 
repertoire expression in different individuals. It also shows the relative 
overexpression of some TCR V {3 families in PBLs compared to skin and 
vice versa, Specifically, TCR V{318 family is shown to be overexpressed 
in skin of the AA patient, but not in the controL 
in PBLs in our study, compared to the previous finding in which it 
was found to be preferentially expressed in skin. 
Other families were preferentially expressed in skin biopsies: 
V{35,2 (in six of eight samples), V{314 (in six of eight samples), and 
V{322 (in five of eight samples). In the previous report, V{35,2 was 
shown to be overexpressed only in some skin samples, V {314 was also 
preferentially expressed in skin and V{322 was not tested, The differ­
ences found between the two studies could be explained by the 
possibility that we are analyzing a restricted population regarding the 
number, their genetic background (HLA), and their disease condition. 
When the AA samples were compared to the controls, V{318 was 
found to be overexpressed (threefold) in skin in two of the patchy AA 
patients (Fig 1), Because these two skin biopsies were taken at the time 
of an active episode of hair loss, this overexpression could be the result 
of an immune-specific process going on, For this reason we analyzed 
the TCR V {318 rearrangements sequences. PCR products were cloned 
in the pAMPI system (Gibco BRL, Gaithersburg, MD) and sequenced 
using the Sanger dideoxy chain termination method [4]. 
To allow for specific T-cell recognition of a vast array of foreign 
antigens in our environment, TCR elements undergo genetic mech­
anisms of diversification, This includes somatic rearrangements of the 
V(D)J segments, addition of non-germline-encoded nucleotides dur­
ing these joining events (N region diversity) and pairing of different ex 
and {3 chains, Functional TCR repertoire, which is used in response to 
a particular peptide antigen, is often quite restricted, 
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Sequence analysis of the joining regions VDJC of the two patients 
v'lith patchy AA showed an interesting pattern in the diversity region. 
All the sequences shared one or two proline residues at the beginning 
of this region. In the control TCR V{318 sequences one proline residue 
was also found. In contrast , in the AU patient different and non-related 
sequences were found in the diversity region. 
Interestingly, one same motif was found in both patchy AA 
patients. Surprisingly, this CDR3 region specificity arose as a conse­
quence of two different J region rearrangements, suggesting a specific 
selected rearrangement rather than a random event, and possibly 
relevant to AA . We are in the process of extending the TCR V {3 
repertoire and sequencing analysis to other AA patients with relative 
recent onset of the disease, long-standing AA, and more controls. 
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T
he absence of obvious follicular destruction in alope­
cia areata (AA) lesions suggests that , if there is an 
autoimmune cytopathic effect against a constituent of 
the follicle itse� or an asso� iate structur�, its ta�get 
might be a funcnonally crUCIal but numencally mmor 
cell population . There is increasing clinical , morphologic , and 
functional evidence suggesting a melanocyte involvement in AA: 1) 
the frequent association of AA with vitiligo , a condition in which 
autoinnnune reactivity against melanocytes has been postulated; 2) 
the frequent sparing of nonpigmented hairs in AA lesions, even 
within an active patch ; 3) the frequent lack of pigment in the initial 
phase of hair regrowth after remission; 4) the structural damage 
shown by melanocytes within hair bulbs affected by early AA 
lesions and the epidermal and/or ocular hypopigmentation, which 
in some cases may occur parallel to the loss of follicular melano­
cytes; 5) the functional abnormalities of the retinal pigment epithe­
lium reported in AA patients, even those without clinically evident 
pigment cell involvement; 6) the description of antibody reactivity 
in sera from AA patients against cultured melanoma cells. 
To search for evidence indicating that a specific autoimmune 
attack against melanocytes is a characteristic event in the develop­
ment of AA, we addressed the question whether or not sera from 
AA patients contain antibodies to specific cell-surface molecules of 
autologous and allogeneic melanocytes in culture . Because of 
previous reports of antimelanocyte antibodies in most cases of 
active vitiligo, melanocyte primary cultures were established from 
unaffected skin of four adult patients with vitiligo, three of whom 
also had current (one case) or past AA (Table I). Melanocytes from 
both the epidermal and dennal portions of the skin biopsies were 
cultured on coverslips, and the viable cells were used in single- and 
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Table I. The Study Patients 
Patient Sex/Age Alopecia Areata Vitiligo 
MUL F/40 First patch at Focal, on both knees and 
age 5; alope- ankles, since age 10 
cia universalis 
since age 12 
PAV F/46 One scalp patch Focal, on < 1 0% body 
at age 16 surface, since age 22 
WYA F/52 Three scalp Extensive, on neck, 
patches at chest, back, hands, and 
age 42 toes, since age 14 
LEW F/58 None Extensive, on chest, axil-
lae, and groin since 
age 9 
double-label immunofluorescence stainings with autologous serum 
and sera from the other three tissue donors . 
In addition to these serum samples , 20 sera from patients with 
active AA were also tested on viable melanocytes cultured from 
neonatal foreskin (obtained from Clonetics). They included six 
recent-onset (less than 6 months) cases, with one or two scalp 
patches, and 14 long-standing (more than 18 months) cases, with 
25-99% of scalp hair loss. The preseuce of circulating melanocyte­
reactive antibodies was investigated on viable melanocytes from 
both autologous skin and neonatal foreskin by standard and com­
plement-fixing immunofluorescence (IF) techniques . Two different 
systems, using either fresh mouse or rabbit serum as a source of 
complement and labeled antibodies against mouse or rabbit C3, 
were employed in the complement-fixing IF procedures , 
As positive controls for human innnunoglobulin binding, sera 
containing non-orgall-specific autoantibodies against cytoplasmic 
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